While MEK activation is predominately associated with melanoma (11), MEK dependency has been documented in a variety of other cancers, including osteosarcoma (12), Ewing sarcoma (13), fibrosarcoma (10,14), and Kaposi sarcoma (15). Here, MAP2K7 is linked to fibrosarcoma.